David J. Wambeke's most recent trade in DiaMedica Therapeutics Inc was a trade of 130,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 1, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
DiaMedica Therapeutics Inc | David J. Wambeke | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 130,000 | 130,000 | - | - | Stock Option (right to buy) | |
DiaMedica Therapeutics Inc | David J. Wambeke | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 3.91 per share. | 23 Jun 2023 | 38,364 | 507,114 (3%) | 0% | 3.9 | 150,003 | Voting Common Shares, no par value per share |
DiaMedica Therapeutics Inc | David J. Wambeke | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 10 Apr 2023 | 468,750 | 468,750 (3%) | 3% | 1.6 | 750,000 | Voting Common Shares, no par value per share |
DiaMedica Therapeutics Inc | David J. Wambeke | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2023 | 140,000 | 140,000 | - | - | Stock Option (right to buy) |